Dr Chi Udeh-Momoh PhD

Translational Neu​roscientist


Dr Chi Udeh-Momoh is a Senior Translational Neuroscientist at BMI. She is at the forefront of developing dementia and healthy brain aging research, education, and care while collaborating with Mental Health and Neuroscience subject experts, clinicians, and educators across the Aga Khan University, to ultimately build the neuroscience capacity and strength at the University. 

Dr Udeh-Momoh has been a Programme and Biomarker Lead for several large-scale dementia prevention studies, including the world-class Imperial College London UK-led longitudinal CHARIOT: PRO cohort with over 2000 cognitively healthy older adults screened, and data on imaging and fluid biomarkers as well as neurocognitive and lifestyle factors collected at high throughput. She is also an Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute, University of San Francisco, California, USA.  

Having completed a competitive CASE PhD studentship in Neuroscience and Neuroendocrinology at the MRC Centre for Synaptic Plasticity at the University of Bristol (2010-2014), her current research focuses on elucidating dementia prevention bio-mechanistic pathways and strategies across diverse populations, with multiple grants and awards to execute this work. 

In 2018, she founded the WWFINGER-AFRICA project that aims to promote brain health and mitigate biomarker-access inequalities through culturally appropriate, sustainable multimodal intervention strategies in Sub-Saharan African populations and identify related molecular mechanisms contributing to observed effects. She is co-Lead of the World-Wide FINGERS Biomarker Consortium and on the Executive committee for the Biofluids-biomarker-based PIA of the Alzheimer’s Association ISTAART (2018 - present). She is also a co-founder of the Female Brain and Endocrine Research (FEMBER) consortium. In addition, Dr Udeh-Momoh leads multinational initiatives to address gender and racial disparities in medical research and academia as part of the Opportunity Committee at Imperial College and further sits on the Board of Trustees of the British Society for Neuroendocrinology as the Equality and Diversity Inclusion Lead.​​

Overall, Dr. Udeh-Momoh's work is at the forefront of translational neuroscience, bringing together fundamental discoveries in neuroscience with the goal of improving human health and wellbeing.​